{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T20:06:46Z","timestamp":1793995606491,"version":"4.8.0"},"reference-count":129,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:00:00Z","timestamp":1768521600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>\n                    Human cytomegalovirus (HCMV), recognized as the largest known DNA virus in the\n                    <jats:italic>Herpesviridae<\/jats:italic>\n                    family, is widely disseminated throughout the human population and poses a substantial threat to public health. HCMV is highly infectious. A majority of HCMV-infected individuals usually exhibit asymptomatic latent infections, while the immunocompromised or immunosuppressed populations infected with HCMV have high mortality. HCMV has long stood as a hot topic of research in the international virology community, and elucidating its pathogenic mechanisms is broadly regarded as a prerequisite for the development of vaccines and effective therapeutic drugs. This review presents a comprehensive and detailed analysis of the advances in the biological characteristics, pathogenesis, virus-host interactions, and the preventive and therapeutic strategies targeting HCMV infection. It will provide valuable insights and references for uncovering the pathogenic mechanisms of HCMV, identifying new drug targets, and developing potential immunotherapies.\n                  <\/jats:p>","DOI":"10.3389\/fimmu.2025.1636978","type":"journal-article","created":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T05:22:53Z","timestamp":1768540973000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Recent advances in human cytomegalovirus: a comprehensive review of pathogenic mechanisms, virus-host interactions, and antiviral strategies"],"prefix":"10.3389","volume":"16","author":[{"given":"Ying","family":"Xia","sequence":"first","affiliation":[{"name":"Department of Central Laboratory, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science","place":["Xiangyang, Hubei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science","place":["Xiangyan, Hubei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaochuan","family":"Shui","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science","place":["Xiangyan, Hubei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Pathology and Blood Transfusion, The 991st Hospital of the Chinese People\u2019s Liberation Army Joint Logistic Support Force","place":["Xiangyang, Hubei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuaijie","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Central Laboratory, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science","place":["Xiangyang, Hubei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenqi","family":"Chai","sequence":"additional","affiliation":[{"name":"Department of Central Laboratory, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science","place":["Xiangyang, Hubei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Central Laboratory, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science","place":["Xiangyang, Hubei, China"]},{"name":"Shenzhen Key Laboratory of Pathogen and Immunity, National Clinical Research Center for infectious disease, State Key Discipline of Infectious Disease, Shenzhen Third People\u2019s Hospital, Second Hospital Affiliated to Southern University of Science and Technology","place":["Shenzhen, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Shen","sequence":"additional","affiliation":[{"name":"Department of Central Laboratory, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science","place":["Xiangyang, Hubei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunhua","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Central Laboratory, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science","place":["Xiangyang, Hubei, China"]},{"name":"Department of Clinical Laboratory, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science","place":["Xiangyan, Hubei, China"]},{"name":"Department of Clinical Laboratory, Xiangyang No. 1 People\u2019s Hospital, Hubei University of Medicine","place":["Xiangyang, Hubei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e2034","DOI":"10.1002\/rmv.2034","article-title":"Estimation of the worldwide seroprevalence of cytomegalovirus: A systematic review and meta-analysis","volume":"29","author":"Zuhair","year":"2019","journal-title":"Rev Med Virol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"16112","DOI":"10.3390\/ijms242216112","article-title":"The quest for immunity: exploring human herpesviruses as vaccine vectors","volume":"24","author":"Kamel","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-024-01186-2","article-title":"Immune surveillance of cytomegalovirus in tissues","volume":"21","author":"Mihali\u0107","year":"2024","journal-title":"Cell Mol Immunol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"e0032623","DOI":"10.1128\/mbio.00326-23","article-title":"Chromatin control of human cytomegalovirus infection","volume":"14","author":"Matthews","year":"2023","journal-title":"mBio"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.655","article-title":"Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection","volume":"20","author":"Cannon","year":"2010","journal-title":"Rev Med Virol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2023.03.020","article-title":"Oral antiviral drugs for treatment of cytomegalovirus in transplant recipients","volume":"29","author":"Razonable","year":"2023","journal-title":"Clin Microbiol Infect"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-021-00582-z","article-title":"Pathogenesis of human cytomegalovirus in the immunocompromised host","volume":"19","author":"Griffiths","year":"2021","journal-title":"Nat Rev Microbiol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"e0031323","DOI":"10.1128\/jcm.00313-23","article-title":"Maternal and congenital human cytomegalovirus infection: laboratory testing for detection and diagnosis","volume":"62","author":"Leber","year":"2024","journal-title":"J Clin Microbiol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.00965-15","article-title":"Differentiation-coupled induction of human cytomegalovirus replication by union of the major enhancer retinoic acid, cyclic AMP, and NF-\u03baB response elements","volume":"89","author":"Yuan","year":"2015","journal-title":"J Virol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.3390\/v16121809","article-title":"Modulation of monocyte effector functions and gene expression by human cytomegalovirus infection","volume":"16","author":"Planchon","year":"2024","journal-title":"Viruses"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e2221797120","DOI":"10.1073\/pnas.2221797120","article-title":"Genomic and geographical structure of human cytomegalovirus","volume":"120","author":"Charles","year":"2023","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2020.00130","article-title":"Cytomegalovirus latency and reactivation: an intricate interplay with the host immune response","volume":"10","author":"Forte","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e1012285","DOI":"10.1371\/journal.ppat.1012285","article-title":"Viral microRNA regulation of Akt is necessary for reactivation of Human Cytomegalovirus from latency in CD34+ hematopoietic progenitor cells and humanized mice","volume":"20","author":"Diggins","year":"2024","journal-title":"PloS Pathog"},{"key":"B14","doi-asserted-by":"publisher","first-page":"e0461522","DOI":"10.1128\/spectrum.04615-22","article-title":"Mitofusin 1-mediated redistribution of mitochondrial antiviral signaling protein promotes type 1 interferon response in human cytomegalovirus infection","volume":"11","author":"Huang","year":"2023","journal-title":"Microbiol Spectr"},{"key":"B15","doi-asserted-by":"publisher","first-page":"e112351","DOI":"10.15252\/embj.2022112351","article-title":"Structural mechanism of CRL4-instructed STAT2 degradation via a novel cytomegaloviral DCAF receptor","volume":"42","author":"Le-Trilling","year":"2023","journal-title":"EMBO J"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1170300","article-title":"Deletion of the non-adjacent genes UL148 and UL148D impairs human cytomegalovirus-mediated TNF receptor 2 surface upregulation","volume":"14","author":"Le-Trilling","year":"2023","journal-title":"Front Immunol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1038\/s41467-024-45614-3","article-title":"Human cytomegalovirus exploits STING signaling and counteracts IFN\/ISG induction to facilitate infection of dendritic cells","volume":"15","author":"Costa","year":"2024","journal-title":"Nat Commun"},{"key":"B18","doi-asserted-by":"publisher","first-page":"e0172421","DOI":"10.1128\/mbio.01724-21","article-title":"Advances in model systems for human cytomegalovirus latency and reactivation","volume":"13","author":"Crawford","year":"2022","journal-title":"mBio"},{"key":"B19","doi-asserted-by":"publisher","first-page":"8757","DOI":"10.3390\/ijms24108757","article-title":"Monocyte differentiation and heterogeneity: inter-subset and interindividual differences","volume":"24","author":"Williams","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiae469","article-title":"Comparative emergence of maribavir and ganciclovir resistance in a randomized phase 3 clinical trial for treatment of cytomegalovirus infection","volume":"231","author":"Chou","year":"2025","journal-title":"J Infect Dis"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.02552-14","article-title":"The human cytomegalovirus UL26 protein antagonizes NF-\u03baB activation","volume":"88","author":"Mathers","year":"2014","journal-title":"J Virol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1735466100","article-title":"Reevaluation of human cytomegalovirus coding potential","volume":"100","author":"Murphy","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2334032100","article-title":"Functional profiling of a human cytomegalovirus genome","volume":"100","author":"Dunn","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiz208","article-title":"Human cytomegalovirus genomes sequenced directly from clinical material: variation, multiple-strain infection, recombination, and gene loss","volume":"220","author":"Su\u00e1rez","year":"2019","journal-title":"J Infect Dis"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.3390\/v15081703","article-title":"Insights into the transcriptome of human cytomegalovirus: A comprehensive review","volume":"15","author":"Zeng","year":"2023","journal-title":"Viruses"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.1053139","article-title":"The human cytomegalovirus decathlon: Ten critical replication events provide opportunities for restriction","volume":"10","author":"Turner","year":"2022","journal-title":"Front Cell Dev Biol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s00018-024-05369-y","article-title":"The battle between host antiviral innate immunity and immune evasion by cytomegalovirus","volume":"81","author":"Li","year":"2024","journal-title":"Cell Mol Life Sci"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jcv.2006.03.005","article-title":"Cytomegalovirus disease in the era of highly active antiretroviral therapy (HAART)","volume":"37","author":"Steininger","year":"2006","journal-title":"J Clin Virol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1086\/644772","article-title":"Racial and sex disparities in life expectancy losses among HIV-infected persons in the United States: impact of risk behavior, late initiation, and early discontinuation of antiretroviral therapy","volume":"49","author":"Losina","year":"2009","journal-title":"Clin Infect Dis"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jir060","article-title":"Valganciclovir reduces T cell activation in HIV-infected individuals with incomplete CD4+ T cell recovery on antiretroviral therapy","volume":"203","author":"Hunt","year":"2011","journal-title":"J Infect Dis"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e32834640e6","article-title":"Old age and anti-cytomegalovirus immunity are associated with altered T-cell reconstitution in HIV-1-infected patients","volume":"25","author":"Appay","year":"2011","journal-title":"Aids"},{"key":"B32","doi-asserted-by":"publisher","first-page":"624","DOI":"10.3390\/microorganisms8050624","article-title":"Evolution and genetic diversity of primate cytomegaloviruses","volume":"8","author":"Cagliani","year":"2020","journal-title":"Microorganisms"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.75.16.7543-7554.2001","article-title":"Reactivation of latent human cytomegalovirus in CD14(+) monocytes is differentiation dependent","volume":"75","author":"S\u00f6derberg-Naucl\u00e9r","year":"2001","journal-title":"J Virol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.68.3.1597-1604.1994","article-title":"Induction of endogenous human cytomegalovirus gene expression after differentiation of monocytes from healthy carriers","volume":"68","author":"Taylor-Wiedeman","year":"1994","journal-title":"J Virol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2014.00389","article-title":"The intimate relationship between human cytomegalovirus and the dendritic cell lineage","volume":"5","author":"Sinclair","year":"2014","journal-title":"Front Microbiol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.00216-06","article-title":"Lipopolysaccharide, tumor necrosis factor alpha, or interleukin-1beta triggers reactivation of latent cytomegalovirus in immunocompetent mice","volume":"80","author":"Cook","year":"2006","journal-title":"J Virol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.2006.01618.x","article-title":"Does cytomegalovirus play a causative role in the development of various inflammatory diseases and cancer","volume":"259","author":"S\u00f6derberg-Naucl\u00e9r","year":"2006","journal-title":"J Intern Med"},{"key":"B38","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s00430-008-0089-y","article-title":"MHC class I immune evasion in MCMV infection","volume":"197","author":"Doom","year":"2008","journal-title":"Med Microbiol Immunol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2007.10.027","article-title":"Modulation of natural killer cells by human cytomegalovirus","volume":"41","author":"Wilkinson","year":"2008","journal-title":"J Clin Virol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1813183115","article-title":"Human cytomegalovirus US21 protein is a viroporin that modulates calcium homeostasis and protects cells against apoptosis","volume":"115","author":"Luganini","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B41","doi-asserted-by":"publisher","first-page":"e0074923","DOI":"10.1128\/mbio.00749-23","article-title":"The US21 viroporin of human cytomegalovirus stimulates cell migration and adhesion","volume":"14","author":"Luganini","year":"2023","journal-title":"mBio"},{"key":"B42","doi-asserted-by":"publisher","first-page":"812","DOI":"10.3390\/v14040812","article-title":"Tumors and cytomegalovirus: an intimate interplay","volume":"14","author":"Herbein","year":"2022","journal-title":"Viruses"},{"key":"B43","doi-asserted-by":"publisher","first-page":"351","DOI":"10.3390\/biomedicines9040351","article-title":"Potential impact of human cytomegalovirus infection on immunity to ovarian tumors and cancer progression","volume":"9","author":"Cox","year":"2021","journal-title":"Biomedicines"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1002\/med.20018","article-title":"Role of tumor cell immune escape mechanisms in cytomegalovirus-mediated oncomodulation","volume":"25","author":"Cinatl","year":"2005","journal-title":"Med Res Rev"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.27016","article-title":"The emerging role of human cytomegalovirus infection in human carcinogenesis: a review of current evidence and potential therapeutic implications","volume":"10","author":"Naucl\u00e9r","year":"2019","journal-title":"Oncotarget"},{"key":"B46","doi-asserted-by":"publisher","first-page":"408","DOI":"10.3390\/v10080408","article-title":"The human cytomegalovirus, from oncomodulation to oncogenesis","volume":"10","author":"Herbein","year":"2018","journal-title":"Viruses"},{"key":"B47","doi-asserted-by":"publisher","first-page":"15","DOI":"10.2174\/1874357901711010015","article-title":"Cytomegalovirus, macrophages and breast cancer","volume":"11","author":"Pasquereau","year":"2017","journal-title":"Open Virol J"},{"key":"B48","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/s41698-024-00709-4","article-title":"Clinical implications of cytomegalovirus in glioblastoma progression and therapy","volume":"8","author":"Mercado","year":"2024","journal-title":"NPJ Precis Oncol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2023.1202138","article-title":"Human cytomegalovirus in cancer: the mechanism of HCMV-induced carcinogenesis and its therapeutic potential","volume":"13","author":"Yu","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"4271","DOI":"10.3390\/cancers14174271","article-title":"Oncogenic and stemness signatures of the high-risk HCMV strains in breast cancer progression","volume":"14","author":"El Baba","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-023-02709-3","article-title":"EZH2-Myc driven glioblastoma elicited by cytomegalovirus infection of human astrocytes","volume":"42","author":"El Baba","year":"2023","journal-title":"Oncogene"},{"key":"B52","doi-asserted-by":"publisher","first-page":"541","DOI":"10.3390\/cells13060541","article-title":"EZH2-myc hallmark in oncovirus\/cytomegalovirus infections and cytomegalovirus\u2019 Resemblance to oncoviruses","volume":"13","author":"El Baba","year":"2024","journal-title":"Cells"},{"key":"B53","doi-asserted-by":"publisher","first-page":"e0188823","DOI":"10.1128\/jvi.01888-23","article-title":"Human cytomegalovirus modulates mTORC1 to redirect mRNA translation within quiescently infected monocytes","volume":"98","author":"Miller","year":"2024","journal-title":"J Virol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/s41467-017-02624-8","article-title":"Human cytomegalovirus-encoded US9 targets MAVS and STING signaling to evade type I interferon immune responses","volume":"9","author":"Choi","year":"2018","journal-title":"Nat Commun"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jproteome.3c00826","article-title":"Differential contributions of interferon classes to host inflammatory responses and restricting virus progeny production","volume":"23","author":"Lum","year":"2024","journal-title":"J Proteome Res"},{"key":"B56","doi-asserted-by":"publisher","first-page":"e0119124","DOI":"10.1128\/mbio.01191-24","article-title":"Human cytomegalovirus UL23 exploits PD-L1 inhibitory signaling pathway to evade T cell-mediated cytotoxicity","volume":"15","author":"Yuan","year":"2024","journal-title":"mBio"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1080\/21505594.2018.1535785","article-title":"Human monocyte-derived macrophages inhibit HCMV spread independent of classical antiviral cytokines","volume":"9","author":"Becker","year":"2018","journal-title":"Virulence"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1038\/s44319-024-00072-2","article-title":"Novel role of bone morphogenetic protein 9 in innate host responses to HCMV infection","volume":"25","author":"Stempel","year":"2024","journal-title":"EMBO Rep"},{"key":"B59","doi-asserted-by":"publisher","first-page":"e00682\u201318","DOI":"10.1128\/mBio.00682-18","article-title":"Human cytomegalovirus encodes a novel FLT3 receptor ligand necessary for hematopoietic cell differentiation and viral reactivation","volume":"9","author":"Crawford","year":"2018","journal-title":"mBio"},{"key":"B60","doi-asserted-by":"publisher","first-page":"e0186624","DOI":"10.1101\/2023.07.26.550702","article-title":"Raf1 promotes successful Human Cytomegalovirus replication and is regulated by AMPK-mediated phosphorylation during infection","volume":"99","author":"Dunn","year":"2023","journal-title":"bioRxiv"},{"key":"B61","doi-asserted-by":"publisher","first-page":"e1002959","DOI":"10.1371\/journal.ppat.1002959","article-title":"Human cytomegalovirus infection dysregulates the canonical Wnt\/\u03b2-catenin signaling pathway","volume":"8","author":"Angelova","year":"2012","journal-title":"PloS Pathog"},{"key":"B62","doi-asserted-by":"publisher","first-page":"e0124123","DOI":"10.1128\/jvi.01241-23","article-title":"HCMV UL8 interaction with \u03b2-catenin and DVL2 regulates viral reactivation in CD34(+) hematopoietic progenitor cells","volume":"97","author":"Dirck","year":"2023","journal-title":"J Virol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"e2421155122","DOI":"10.1073\/pnas.2421155122","article-title":"RNA-targeted proteomics identifies YBX1 as critical for efficient HCMV mRNA translation","volume":"122","author":"Dickmander","year":"2025","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B64","doi-asserted-by":"publisher","first-page":"e0134221","DOI":"10.1128\/spectrum.01342-21","article-title":"The interferon-inducible human PLSCR1 protein is a restriction factor of human cytomegalovirus","volume":"10","author":"Sadanari","year":"2022","journal-title":"Microbiol Spectr"},{"key":"B65","doi-asserted-by":"publisher","first-page":"e1012058","DOI":"10.1371\/journal.ppat.1012058","article-title":"A UL26-PIAS1 complex antagonizes anti-viral gene expression during Human Cytomegalovirus infection","volume":"20","author":"Ciesla","year":"2024","journal-title":"PloS Pathog"},{"key":"B66","doi-asserted-by":"publisher","first-page":"e1005850","DOI":"10.1371\/journal.ppat.1005850","article-title":"Consecutive inhibition of ISG15 expression and ISGylation by cytomegalovirus regulators","volume":"12","author":"Kim","year":"2016","journal-title":"PloS Pathog"},{"key":"B67","doi-asserted-by":"publisher","first-page":"e1011682","DOI":"10.1371\/journal.ppat.1011682","article-title":"Proximity-dependent mapping of the HCMV US28 interactome identifies RhoGEF signaling as a requirement for efficient viral reactivation","volume":"19","author":"Medica","year":"2023","journal-title":"PloS Pathog"},{"key":"B68","doi-asserted-by":"publisher","first-page":"eabl5442","DOI":"10.1126\/sciadv.abl5442","article-title":"Atypical structural snapshots of human cytomegalovirus GPCR interactions with host G proteins","volume":"8","author":"Tsutsumi","year":"2022","journal-title":"Sci Adv"},{"key":"B69","doi-asserted-by":"publisher","first-page":"eadi6586","DOI":"10.1126\/sciadv.adi6586","article-title":"Human cytomegalovirus UL36 inhibits IRF3-dependent immune signaling to counterbalance its immunoenhancement as apoptotic inhibitor","volume":"9","author":"Ren","year":"2023","journal-title":"Sci Adv"},{"key":"B70","doi-asserted-by":"publisher","first-page":"e1011185","DOI":"10.1371\/journal.ppat.1011185","article-title":"Human cytomegalovirus UL138 interaction with USP1 activates STAT1 in infection","volume":"19","author":"Zarrella","year":"2023","journal-title":"PloS Pathog"},{"key":"B71","doi-asserted-by":"publisher","first-page":"e1011166","DOI":"10.1371\/journal.ppat.1011166","article-title":"Human cytomegalovirus pUL97 upregulates SOCS3 expression via transcription factor RFX7 in neural progenitor cells","volume":"19","author":"Wang","year":"2023","journal-title":"PloS Pathog"},{"key":"B72","doi-asserted-by":"publisher","first-page":"17421","DOI":"10.3390\/ijms242417421","article-title":"The interactive complex between cytomegalovirus kinase vCDK\/pUL97 and host factors CDK7-cyclin H determines individual patterns of transcription in infected cells","volume":"24","author":"Sch\u00fctz","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B73","doi-asserted-by":"publisher","first-page":"11814","DOI":"10.3390\/ijms231911814","article-title":"Highly conserved interaction profiles between clinically relevant mutants of the cytomegalovirus CDK-like kinase pUL97 and human cyclins: functional significance of cyclin H","volume":"23","author":"Sch\u00fctz","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2022.102513","article-title":"Serine 13 of the human cytomegalovirus viral cyclin-dependent kinase UL97 is required for regulatory protein 14-3\u20133 binding and UL97 stability","volume":"298","author":"Iwahori","year":"2022","journal-title":"J Biol Chem"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.02683-20","article-title":"The zinc finger antiviral protein ZAP restricts human cytomegalovirus and selectively binds and destabilizes viral UL4\/UL5 transcripts","volume":"12","author":"Gonzalez-Perez","year":"2021","journal-title":"mBio"},{"key":"B76","doi-asserted-by":"publisher","first-page":"7640","DOI":"10.1038\/s41467-024-51961-y","article-title":"Human cytomegalovirus harnesses host L1 retrotransposon for efficient replication","volume":"15","author":"Hwang","year":"2024","journal-title":"Nat Commun"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1080\/21505594.2021.2000689","article-title":"Site-specific SUMOylation of viral polymerase processivity factor: a way of localizingtoND10 subnuclear domains for restricted and self-controlled reproduction of herpesvirus","volume":"12","author":"Lai","year":"2021","journal-title":"Virulence"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.652719","article-title":"Sumoylation of the carboxy-terminal of human cytomegalovirus DNA polymerase processivity factor UL44 attenuates viral DNA replication","volume":"12","author":"Chen","year":"2021","journal-title":"Front Microbiol"},{"key":"B79","doi-asserted-by":"publisher","first-page":"e2309077120","DOI":"10.1073\/pnas.2309077120","article-title":"HCMV-secreted glycoprotein gpUL4 inhibits TRAIL-mediated apoptosis and NK cell activation","volume":"120","author":"Vlachava","year":"2023","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B80","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/s42003-025-07674-z","article-title":"Human cytomegalovirus UL82 promotes cell cycle progression of colorectal cancer by upregulating AGR2","volume":"8","author":"Ren","year":"2025","journal-title":"Commun Biol"},{"key":"B81","doi-asserted-by":"publisher","first-page":"e4915","DOI":"10.1002\/pro.4915","article-title":"Crystal structure of the tegument protein UL82 (pp71) from human cytomegalovirus","volume":"33","author":"Eberhage","year":"2024","journal-title":"Protein Sci"},{"key":"B82","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1146\/annurev-med-042921-124739","article-title":"Cytomegalovirus therapy: role of letermovir in prophylaxis and treatment in transplant recipients","volume":"74","author":"Saullo","year":"2023","journal-title":"Annu Rev Med"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2023.1321116","article-title":"Anti-CMV therapy, what next? A systematic review","volume":"14","author":"Gourin","year":"2023","journal-title":"Front Microbiol"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1038\/359085a0","article-title":"A protein kinase homologue controls phosphorylation of ganciclovir in human cytomegalovirus-infected cells","volume":"359","author":"Sullivan","year":"1992","journal-title":"Nature"},{"key":"B85","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1186\/s12879-024-09255-7","article-title":"Cytomegalovirus colitis as intestinal obstruction in an immunocompetent adolescent: a case report and literature review","volume":"24","author":"Ge","year":"2024","journal-title":"BMC Infect Dis"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.3109\/09273949609079641","article-title":"Treatment of CMV retinopathy in patients with AIDS","volume":"4","author":"Tay-Kearney","year":"1996","journal-title":"Ocul Immunol Inflamm"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-018-0943-1","article-title":"New developments in the management of cytomegalovirus infection after transplantation","volume":"78","author":"Meesing","year":"2018","journal-title":"Drugs"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms11102372","article-title":"Antiviral approach to cytomegalovirus infection: an overview of conventional and novel strategies","volume":"11","author":"Bottino","year":"2023","journal-title":"Microorganisms"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa011759","article-title":"A controlled trial of valganciclovir as induction therapy for cytomegalovirus retinitis","volume":"346","author":"Martin","year":"2002","journal-title":"N Engl J Med"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1016\/s1473-3099(24)00359-1","article-title":"Renal transplantation using kidneys from a donor with high grade cytomegalovirus viraemia: case report and literature review","volume":"24","author":"Shirini","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(05)66553-1","article-title":"Antiviral medications to prevent cytomegalovirus disease and early death in recipients of solid-organ transplants: a systematic review of randomized controlled trials","volume":"365","author":"Hodson","year":"2005","journal-title":"Lancet"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.21183","article-title":"Cytomegalovirus prophylaxis with valganciclovir in cytomegalovirus-seropositive kidney-transplant patients","volume":"80","author":"W\u00e9clawiak","year":"2008","journal-title":"J Med Virol"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1093\/femsre\/fuy004","article-title":"The human cytomegalovirus terminase complex as an antiviral target: a close-up view","volume":"42","author":"Ligat","year":"2018","journal-title":"FEMS Microbiol Rev"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-024-01437-5","article-title":"Drug-drug interaction management with the novel anti-cytomegalovirus agents letermovir and maribavir: guidance for clinicians","volume":"63","author":"Burger","year":"2024","journal-title":"Clin Pharmacokinet"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2011.01.006","article-title":"Antiviral inhibition targeting the HCMV kinase pUL97 requires pUL27-dependent degradation of Tip60 acetyltransferase and cell-cycle arrest","volume":"9","author":"Reitsma","year":"2011","journal-title":"Cell Host Microbe"},{"key":"B96","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.3390\/v15061358","article-title":"An update on current antiviral strategies to combat human cytomegalovirus infection","volume":"15","author":"Panda","year":"2023","journal-title":"Viruses"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1128\/aac.43.3.557","article-title":"Comparative study of the anti-human cytomegalovirus activities and toxicities of a tetrahydrofuran phosphonate analogue of guanosine and cidofovir","volume":"43","author":"Bedard","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-126-4-199702150-00001","article-title":"Intravenous cidofovir for peripheral cytomegalovirus retinitis in patients with AIDS. A randomized, controlled trial","volume":"126","author":"Lalezari","year":"1997","journal-title":"Ann Intern Med"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/166.3.473","article-title":"Phase I-II trial of foscarnet for prevention of cytomegalovirus infection in autologous and allogeneic marrow transplant recipients","volume":"166","author":"Reusser","year":"1992","journal-title":"J Infect Dis"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1016\/0924-8579(95)00008-v","article-title":"Pharmacology and clinical use of foscarnet","volume":"5","author":"G\u00e9rard","year":"1995","journal-title":"Int J Antimicrob Agents"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1128\/aac.33.5.736","article-title":"Foscarnet treatment of cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome","volume":"33","author":"Jacobson","year":"1989","journal-title":"Antimicrob Agents Chemother"},{"key":"B102","doi-asserted-by":"publisher","first-page":"e202400629","DOI":"10.1002\/cmdc.202400629","article-title":"Discovery of novel pyrido[2,3-b]Pyrazine human cytomegalovirus polymerase inhibitors with broad spectrum antiherpetic activity and reduced hERG inhibition","volume":"20","author":"Bai","year":"2025","journal-title":"ChemMedChem"},{"key":"B103","doi-asserted-by":"publisher","first-page":"575","DOI":"10.3390\/ijms22020575","article-title":"Combinatorial drug treatments reveal promising anticytomegaloviral profiles for clinically relevant pharmaceutical kinase inhibitors (PKIs)","volume":"22","author":"Wild","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B104","doi-asserted-by":"publisher","first-page":"2680","DOI":"10.3390\/pharmaceutics15122680","article-title":"Combined treatment with host-directed and anticytomegaloviral kinase inhibitors: mechanisms, synergisms and drug resistance barriers","volume":"15","author":"Wild","year":"2023","journal-title":"Pharmaceutics"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1002\/cpdd.1542","article-title":"Pharmacokinetics and safety study of HN0141, a novel anti-human cytomegalovirus inhibitor, in healthy volunteers","volume":"14","author":"Hill","year":"2025","journal-title":"Clin Pharmacol Drug Dev"},{"key":"B106","doi-asserted-by":"publisher","first-page":"e0016023","DOI":"10.1128\/jvi.00160-23","article-title":"Harnessing the noncanonical keap1-nrf2 pathway for human cytomegalovirus control","volume":"97","author":"Ghosh","year":"2023","journal-title":"J Virol"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2021.105124","article-title":"Valspodar limits human cytomegalovirus infection and dissemination","volume":"193","author":"Parsons","year":"2021","journal-title":"Antiviral Res"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2022.105474","article-title":"Investigating N-arylpyrimidinamine (NAPA) compounds as early-stage inhibitors against human cytomegalovirus","volume":"209","author":"Parsons","year":"2023","journal-title":"Antiviral Res"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1631\/jzus.B2300232","article-title":"Typical hemophagocytic syndrome associated with cytomegalovirus infection in an immunocompetent patient: a case report and literature review","volume":"24","author":"Geng","year":"2023","journal-title":"J Zhejiang Univ Sci B"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.3390\/v13030474","article-title":"Small molecules-prospective novel HCMV inhibitors","volume":"13","author":"Bogner","year":"2021","journal-title":"Viruses"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-022-00495-3","article-title":"Antibodies to combat viral infections: development strategies and progress","volume":"21","author":"Pantaleo","year":"2022","journal-title":"Nat Rev Drug Discov"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-07-729756","article-title":"MVA vaccine encoding CMV antigens safely induces durable expansion of CMV-specific T cells in healthy adults","volume":"129","author":"La Rosa","year":"2017","journal-title":"Blood"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.7326\/m19-2511","article-title":"Poxvirus vectored cytomegalovirus vaccine to prevent cytomegalovirus viremia in transplant recipients: A phase 2, randomized clinical trial","volume":"172","author":"Aldoss","year":"2020","journal-title":"Ann Intern Med"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1080\/21505594.2023.2169488","article-title":"CRM197-conjugated peptides vaccine of HCMV pp65 and gH induce maturation of DC and effective viral-specific T cell responses","volume":"14","author":"Zhang","year":"2023","journal-title":"Virulence"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiz141","article-title":"Phase 1 clinical trial of a conditionally replication-defective human cytomegalovirus (CMV) vaccine in CMV-seronegative subjects","volume":"220","author":"Adler","year":"2019","journal-title":"J Infect Dis"},{"key":"B116","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/s41541-024-00860-w","article-title":"Transcriptional signature of durable effector T cells elicited by a replication defective HCMV vaccine","volume":"9","author":"Ye","year":"2024","journal-title":"NPJ Vaccines"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2023.1189805","article-title":"Hematopoietic stem cells and betaherpesvirus latency","volume":"13","author":"Crawford","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1016\/s0966-842x(03)00066-0","article-title":"Human cytomegalovirus retinitis: pathogenicity, immune evasion and persistence","volume":"11","author":"Scholz","year":"2003","journal-title":"Trends Microbiol"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1016\/j.omto.2020.01.007","article-title":"Uncovering the anticancer potential of murine cytomegalovirus against human colon cancer cells","volume":"16","author":"Massara","year":"2020","journal-title":"Mol Ther Oncolytics"},{"key":"B120","doi-asserted-by":"publisher","first-page":"eadp5216","DOI":"10.1126\/sciimmunol.adp5216","article-title":"Human cytomegalovirus UL18 prevents priming of MHC-E- and MHC-II-restricted CD8(+) T cells","volume":"9","author":"Malouli","year":"2024","journal-title":"Sci Immunol"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26020287","article-title":"The UFM1 Pathway Impacts HCMV US2-Mediated Degradation of HLA Class I","volume":"26","author":"Schuren","year":"2021","journal-title":"Molecules"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jix043","article-title":"Modulation of the host environment by human cytomegalovirus with viral interleukin 10 in peripheral blood","volume":"215","author":"Young","year":"2017","journal-title":"J Infect Dis"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1002\/med.20030","article-title":"Design of translactam HCMV protease inhibitors as potent antivirals","volume":"25","author":"Borthwick","year":"2005","journal-title":"Med Res Rev"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1128\/aac.00114-15","article-title":"In vitro drug combination studies of Letermovir (AIC246, MK-8228) with approved anti-human cytomegalovirus (HCMV) and anti-HIV compounds in inhibition of HCMV and HIV replication","volume":"59","author":"Wildum","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1007\/bf01961133","article-title":"Activity of different antiviral drug combinations against human cytomegalovirus replication in vitro","volume":"11","author":"Snoeck","year":"1992","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1016\/j.placenta.2014.11.003","article-title":"Ex vivo model of congenital cytomegalovirus infection and new combination therapies","volume":"36","author":"Mor\u00e8re","year":"2015","journal-title":"Placenta"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1704694","article-title":"Use of leflunomide in an allogeneic bone marrow transplant recipient with refractory cytomegalovirus infection","volume":"34","author":"Avery","year":"2004","journal-title":"Bone Marrow Transplant"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1002\/med.21281","article-title":"A cutting-edge view on the current state of antiviral drug development","volume":"33","author":"De Clercq","year":"2013","journal-title":"Med Res Rev"},{"key":"B129","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1128\/cmr.00009-10","article-title":"Antiviral drug resistance of human cytomegalovirus","volume":"23","author":"Lurain","year":"2010","journal-title":"Clin Microbiol Rev"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1636978\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T07:34:31Z","timestamp":1771918471000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1636978\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,16]]},"references-count":129,"alternative-id":["10.3389\/fimmu.2025.1636978"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1636978","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,16]]},"article-number":"1636978"}}